natures (16 -21) . Several types of viruses, including influenza A virus, dengue virus, hepatitis C virus, adenovirus, varicella zoster virus, encephalomyocarditis virus, vesicular stomatitis virus, myxoma virus, and respiratory syncytial virus have been found to induce IL-1␤ through the NLRP3 inflammasome (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . Interestingly, HIV-1 infection has been reported to induce NLRP3 mRNA expression in monocyte-derived dendritic cells (32) , and an SNP at the 3Ј UTR of the NLRP3 gene is associated with susceptibility to HIV-1 infection (33) . However, it is not clear whether HIV-1 infection leads to activation of the NLRP3 inflammasome.
In this report, we found that HIV-1 infection induced IL-1␤ production and caspase-1 activation in human monocytes. Using the siRNA approach, we showed that TLR8, but not TLR7, was required for the induction of pro-IL-1␤ expression and that the NLRP3 inflammasome was required for IL-1␤ maturation and release. We found that reactive oxygen species (ROS) were increased in the HIV-1-infected monocytic cells, which was also critical for HIV-induced IL-1␤ production. Cathepsin B, a lysosomal protease that has been reported to be an activator of NLRP3 (34, 35) , was also important for HIV-1induced IL-1␤ production. HIV-1 entry, reverse transcription, and integration were all required for both pro-IL-1␤ expression and caspase-1 activation. Finally, we found that HIV-1 derived RNA was sufficient to induce both pro-IL-1␤ expression and caspase-1 activation. We conclude that HIV-1 infection induced IL-1␤ production by induction of pro-IL-1␤ through a TLR8-dependent mechanism and activation of the NLRP3 inflammasome involving ROS and cathepsin B induction.
EXPERIMENTAL PROCEDURES
Cell Culture-The human monocytic cell line THP-1 was maintained in RPMI 1640 medium (Invitrogen) containing 10% FBS and 1% penicillin/streptomycin. THP-1 cells containing scramble shRNA or shRNA for NLRP3, ASC, NLRC4 (36, 37) , MyD88 mutants, MyD88, TRAF6 mutants, TRAF6 (38) , TLR7, and TLR8 were cultured under the same conditions as THP-1, as described previously. Human peripheral blood mononuclear cells (PBMCs) were isolated from the buffy coat by Ficoll-Paque Plus and maintained in RPMI 1640 medium containing 10% FBS, 1% penicillin/streptomycin, and 1% nonessential amino acids. Primary human monocytes were isolated from PBMCs by negative selection using the human monocyte enrichment kit from Stemcell Technologies and were maintained in Iscove's modified Dulbecco's medium containing 10% FBS, 1% penicillin/streptomycin, and 1% nonessential amino acids. Primary human macrophages were differentiated from monocytes by culturing in medium containing 20 ng/ml recombinant human monocyte colony-stimulating factor (PeproTech, Rock Hill, NJ) for 7 days. All cells were maintained at 37°C in 5% carbon dioxide.
Reagents and Antibodies-Z-VAD-fmk, Ac-YVAD-CHO, (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylic acid (APDC) and CA-074 Me were from Enzo Life Sciences (Farmingdale, NY). Chloroquine, ssRNA40, and ssRNA41 were from Invivogen (San Diego, CA). Soluble CD4, enfuvirtide (T20), nevirapine (NVP), zidovudine (AZT), raltegravir, and amprenavir were from the National Institutes of Health AIDS Research and Ref-erence Reagent Program. Antibodies used for immunoblotting included anti-IL-1␤ (catalog no. 2022, Cell Signaling Technology, Danvers, MA) and anti-caspase-1 p10 (catalog no. sc-515, Santa Cruz Biotechnology, Santa Cruz, CA).
Preparation of the shRNA Plasmid and Cell Lines for TLR Knockdown-The human 7 SK RNA polymerase III promoter and the shRNA sequence for human TLR7 and TLR8 were amplified by PCR from plasmid psiRNA-TLR7, psiRNA-TLR8 from Invivogen and inserted into lentiviral vector FG12 by XhoI and XbaI. Lentiviruses were made by cotransfection of lentiviral vector, VSVG, and ⌬NRF into 293T cells. THP-1 cells were infected by lentiviruses containing shRNA for TLR7 or TLR8 by spinoculation (5500 rpm and 25°C for 3 h) to generate the TLR7 or TLR8 knockdown cell line. Transduced cells were sorted by the GFP marker.
Virus Propagation-293T cells were transfected with the HIV-R3A proviral plasmid, and the cell-free supernatant was collected and filtered with a 0.45-M filter. HIV-1 p24 was measured by p24 ELISA. SupT1 cells were infected by 293Tderived viruses, and cell-free supernatants were collected and filtered on different days after infection. PBMCs were cultured in medium containing 5 g/ml phytohemagglutinin and 20 units/ml IL-2 for 3 days and then infected with 293T-derived viruses for 3 h. PBMCs were maintained in medium containing 20 units/ml IL-2, and cell-free supernatants were collected and filtered on different days after infection. HIV p24 was measured for SupT1-and PBMC-derived viral stocks, and supernatants containing more than 100 ng/ml of p24 were used. The infectious unit was determined by infecting the Magi-R5 reporter cell line (39) . The infectivity of the viral stock was about 1 ϫ 10 4 infectious units/ng p24.
HIV-1 Infection of Human Primary Cells and Cell Lines-4 ϫ 10 5 THP-1 cells were incubated with 20 ng of p24 (SupT1derived HIV-1 stocks, multiplicity of infection of 0.5) plus 8 g/ml of Polybrene for 10 min at room temperature, and then spinoculation was performed at 900 ϫ g at 37°C for 3 h. 4 ϫ 10 5 human primary monocytes were incubated with PBMC-derived HIV-1 stocks (20 ng of p24, multiplicity of infection of 0.5) as above. Cells were then washed three times and divided into 96-well plates with 10 5 cells/well in triplicate wells. Human macrophages were cultured in 96-well plates with 10 5 cells/well and infected with PBMC-derived HIV-1 (10 ng of p24, multiplicity of infection of 1) plus 8 g/ml of Polybrene for 3 h. Cells were then washed three times with medium. For pharmacological assessments, cells were treated with Z-VAD-fmk (25 or 50 M), Ac-YVAD-CHO (25 or 50 M), APDC (100 M), CA-074 Me (25 M), T20 (10 g/ml), NVP (2 M), AZT (5 M), raltegravir (10 M), and amprenavir (10 M) for 1 h before infection and then cultured in the presence of those drugs. For blocking viral entry, viruses were incubated with sCD4 (10 g/ml) at 37°C for 30 min before infection.
Human Monocyte and Macrophage Transfection-10 7 of fresh isolated primary monocytes or primary macrophages differentiated by 20 ng/ml of M-CSF were nucleofected with 30 pmol of control siRNA, siRNA for NLRP3, or siRNA for ASC. The nucleofected cells were cultured for 48 h before infection. All siRNAs used were from Ambion.
Real-time PCR-Real-time PCR was performed to detect NLRP3, ASC, and 18 S rRNA expression by TaqMan gene expression assays (Hs00918082_m1, Hs00203118_m1, and Hs99999901_s1) (Applied Biosystems, Carlsbad, CA) and TLR7, TLR8, IL-1␤, and GAPDH expression by SYBR Green and the following primers: TLR7, 5Ј-AAACTCCTTGGGGCT-AGATG-3Ј (forward) and 5Ј-AGGGTGAGGTTCGTGGT-GTT-3Ј (reverse); TLR8, 5Ј-CTGTGAGTTATGCGCCGA-AGA-3Ј (forward) and 5Ј-TGGTGCTGTACATTGGGGTTG-3Ј (reverse); IL-1␤, 5Ј-ACAGTGGCAATGAGGATGAC-3Ј (forward) and 5Ј-CCATGGCCACAACAACTGA-3Ј (reverse); and GAPDH, 5Ј-ATGTTCGTCATGGGTGTGAA-3Ј (forward) and 5Ј-GTCTTCTGGGTGGCAGTGAT-3Ј (reverse).
ELISA-Cell-free supernatants were analyzed for IL-1␤ expression using an IL-1␤ ELISA kit (BD Biosciences) according to the instructions of the manufacturer.
ROS Detection-THP-1 cells were infected with HIV-1 and, at different time points after infection, cells were loaded with 10 M fluoroprobe dihydrorhodamine 123 (AnaSpec, Fremont, CA) for 30 min and washed twice with Hanks' balanced salt solution containing calcium and magnesium but no phenol red. Cells were fixed with 10% formalin, and the mean fluorescence intensity was determined using a CyAn ADP flow cytometer (DAKO, Carpinteria, CA).
Detection of Caspase-1 Activation-THP-1 cells were infected with HIV-1 and loaded with caspase-1 FLICA (Immunochemistry Technologies, Bloomington, MN) at 3 dpi according to the instructions of the manufacturer. Caspase-1-positive cells were determined by a CyAn ADP flow cytometer (DAKO).
Statistics-Data are presented as the mean Ϯ S.E. Data were analyzed for statistical significance by two-tailed Student's t test in Excel (Microsoft). In all cases, p Ͻ 0.05 was considered to be statistically significant.
RESULTS

HIV-1 Infection Induces IL-1␤ Production in human Monocytic Cells-To test whether HIV-1 infection of monocytes/
macrophages can induce IL-1␤ production, we used the CXCR4/CCR5 dual tropic HIV-R3A virus, which infects both T cells and macrophages (40, 41) . HIV-R3A induced a significant increase of IL-1␤ in THP-1 (a human monocytic cell line) in a dose-dependent manner (Fig. 1A ). To confirm this in primary human cells, we infected enriched primary monocytes from human PBMCs (Ͼ80% CD14ϩ). At 24 hpi, IL-1␤ in the super- natant was significantly increased in HIV-1-infected monocytes ( Fig. 1B ) from three different human blood donors. When monocyte-derived macrophages were tested, HIV-R3A infection also significantly induced IL-1␤ production ( Fig. 1C) . A CCR5-tropic and macrophage-tropic HIV-1 strain, YU2, was also able to induce IL-1␤ production in primary macrophages (Fig. 1C ). We used soluble CD4 (sCD4) to block HIV-R3A infection of THP-1 cells (Fig. 1D ). The data showed that blockage of HIV-R3A infection by sCD4 significantly inhibited IL-1␤ production ( Fig. 1D ). Therefore, we conclude that HIV-1 infection of monocytes/macrophages efficiently induced production of IL-1␤.
HIV-1 Infection Induces Pro-IL-1␤ Expression and Caspase-1 Activation to Promote IL-1␤ Production-Production of mature IL-1␤ requires two signals. One activates the expression of pro-IL-1␤, and the other activates the inflammasome and interleukin-1 converting enzyme caspase-1, which cleaves pro-IL-1␤ into mature IL-1␤ (13) . IL-1␤ production induced by HIV-R3A was attenuated dramatically by a pan-caspase inhibitor, Z-VAD-fmk, and by the caspase-1-specific inhibitor Ac-YVAD-CHO ( Fig. 2A ). We also measured the level of active caspase-1 in HIV-R3A-infected THP-1 cells by flow cytometer with the fluorescent labeled caspase-1 inhibitor (FLICA). HIV-R3A infection significantly increased the percentage of cells with activated caspase-1 (Fig. 2B ). These data indicate that HIV-R3A infection activated caspase-1 to promote IL-1␤ production. In the cell lysate, we detected an increase of pro-IL-1␤ in HIV-R3A-infected THP-1 cells (Fig. 2C ), indicating that HIV-1 infection induced expression of pro-IL-1␤. In addition, infected cells treated with Ac-YVAD-CHO accumulated more pro-IL-1␤ in the cytoplasm (Fig. 2D ), indicating that Ac-YVAD-CHO did not affect pro-IL-1␤ induction but inhibited the activation of caspase 1 to generate mature IL-1␤. Consistently, Ac-YVAD-CHO did not affect HIV-R3A infection of THP-1 cells (data not shown). Furthermore, we detected the active caspase-1 p10 and mature IL-1␤ p17 in the supernatant from HIV-R3A-infected THP-1 cells but not from mock cells (Fig. 2D ). Importantly, blockage of HIV-R3A infection of THP-1 with sCD4 abolished both pro-IL-1␤ induction and caspase-1 activation (Fig. 2D ). We conclude that HIV-1 infection of monocytes induces pro-IL-1␤ expression and caspase-1 activation to promote IL-1␤ production.
TLR8 Is Required for HIV-1-induced Pro-IL-1␤ Expression-HIV-1 RNA is reported to activate TLR7 in plasmacytoid den- dritic cell (10) . However, the ssRNA40 RNA derived from HIV-1 has also been reported to promote TNF␣ production via TLR8, but not TLR7, in macrophages (9) . We investigated whether TLR7 or TLR8 was required for the induction of pro-IL-1␤. Preventing acidification of the endosome by chloroquine inhibits the function of endosomal TLRs (42, 43) . Chloroquine blocked HIV-1-induced pro-IL-1␤ expression ( Fig. 3A) and IL-1␤ production (Fig. 3, B and C) . To define the role of TLR7 and TLR8 in HIV-1-induced pro-IL-1␤ expression, shRNA was used to knock down their expression in THP-1 cells (Fig. 3D) . Interestingly, knockdown of TLR8 abolished pro-IL-1␤ induction in HIV-1-infected THP-1 cells, whereas knockdown of TLR7 did not change pro-IL-1␤ induction (Fig. 3, E and F) . Consistently, mature IL-1␤ from supernatants was also reduced dramatically in TLR8, but not TLR7, knockdown cells ( Fig. 3G ). Furthermore, we found that knockdown of downstream MyD88 and TRAF6 also dramatically attenuated pro-IL-1␤ expression ( Fig. 3H ) and IL-1␤ production (Fig. 3I ) induced by HIV-R3A infection. In conclusion, the TLR8/ MyD88/TRAF6 pathway is required for HIV-1-induced pro-IL-1␤ expression in human monocytic cells.
The NLRP3 Inflammasome Is Required for HIV-1-induced IL-1␤ Maturation and Release-To determine whether the NLRP3 inflammasome is involved in HIV-1-induced IL-1␤ production, we utilized shRNA to inhibit NLRP3 or ASC gene expression to assess the contribution of NLRP3 or ASC (36, 37) . Control THP-1 and knockdown cell lines were infected with mock or HIV-R3A. HIV-R3A induced a significant increase of IL-1␤ in parental THP-1 cells and cells transduced with scrambled control shRNA. As expected, a reported NLRP3 agonist, R848 (18), failed to induce IL-1␤ production in THP1 cells transduced with shRNA targeting NLRP3 or ASC (data not shown). HIV-R3A also failed to induce IL-1␤ production in cells with suppressed expression of NLRP3 or ASC (Fig. 4A ). However, inhibition of NLRC4 expression (Ͼ75%, data not shown) did not affect IL-1␤ production induced by HIV-1 infection (Fig. 4A ). Furthermore, HIV-1 infection still induced expression of pro-IL-1␤ in cells with suppressed expression of NLRP3, ASC, or NLRC4 (Fig. 4B ), suggesting that the NLRP3-ASC inflammasome is not involved in HIV-1-induced pro-IL-1␤ expression. Therefore, HIV-1 infection activated the NLRP3 inflammasome to induce IL-1␤ maturation and release.
To confirm that NLRP3 and ASC are required in HIV-R3Ainduced IL-1␤ production in primary monocytes, we transfected primary monocytes purified from human PBMC with siRNA targeting NLRP3 and ASC. A scrambled siRNA was also included as a control. The transfection efficiency of primary monocytes was greater than 90% (data not shown). These cells were infected with HIV-R3A, and IL-1␤ was measured in supernatants collected at 24 hpi. Knockdown of NLRP3 and ASC in primary monocytes was confirmed by quantitative PCR (Fig. 4, C and D) . The induction of IL-1␤ by R848 stimulation was also attenuated significantly in primary monocytes transfected with siRNA targeting NLRP3 and ASC, indicating that NLRP3 and ASC were functionally knocked down (data not shown). As shown above, HIV-1 infection induced a significant increase of IL-1␤ in monocytes transfected with control siRNA. In monocytes transfected with the siRNA for NLRP3 or ASC, IL-1␤ induction by HIV-1 infection was attenuated significantly ( Fig. 4E) . Consistently, we also found that knockdown of NLRP3 or ASC in primary macrophages abolished HIV-1-induced IL-1␤ production (Fig. 4F) . These data suggest that HIV-1 induces IL-1␤ production via the NLRP3 inflammasome in primary monocytes/macrophages.
NLRP3 Inflammasome Activation in Responses to HIV-1 Is Dependent on ROS Production and Cathepsin B-
The induction of ROS is often critical for inflammasome activation (44, 45) . To test whether HIV-R3A infection induced ROS generation, we loaded THP-1 cells with the ROS dye dihydrorhodamine 123 at different time points post-infection. ROS levels increased over time during HIV-1 infection and reached a peak at 48 hpi (Fig. 5A ). We showed that ROS was essential for HIV-1-induced IL-1␤ production because IL-1␤ secretion was totally inhibited by APDC, an NADPH oxidase inhibitor, in both THP-1 cells (Fig. 5B ) and primary monocytes (Fig. 5C) . A specific lysosomal cysteine protease, cathepsin B, has been reported to be associated with NLRP3 inflammasome activation and IL-1␤ production. Utilizing the cathepsin B-specific inhibitor CA-074-Me, we observed a significant attenuation in IL-1␤ release after HIV-R3A infection in both THP-1 cells (Fig.  5D ) and primary monocytes (Fig. 5E ). However, both ROS and cathepsin B inhibitors failed to inhibit HIV-R3A-induced pro-IL-1␤ expression (Fig. 5F ). However, they inhibited caspase-1 activation (Fig. 5G) . Therefore, HIV-1 induced ROS production and cathepsin B activity are required for NLRP3 inflammasome activation.
Productive Infection Is Required for HIV-1-induced Pro-IL-1␤ Expression and NLRP3 Inflammasome Activation-HIV-R3Ainduced IL-1␤ production was not significantly detectable until 48 hpi (Fig. 6, A and B) . Consistently, pro-IL-1␤ expression and caspase-1 activation started to be detectable at 48 hpi (Fig. 6B) . By HIV-1 p24 staining, we found that about 50% of cells were positive at 48 hpi (data not shown). The kinetics of viral replication and pro-IL-1␤/IL-1␤ production were similar, implying that virus-productive infection may be important for HIV-1induced pro-IL-1␤ expression and NLRP3-ASC-caspase-1 activation. To assess which step of viral replication is important for HIV-1-induced pro-IL-1␤ expression and inflammasome activation, we used T20 to block HIV-1 fusion, NVP and AZT to block HIV-1 reverse transcription, raltegravir to block HIV-1 integration, and amprenavir to block HIV-1 protease activity for viral polyprotein cleavage and viral particle maturation. All inhibitors, except the protease inhibitor amprenavir, significantly attenuated IL-1␤ release (Fig. 6C) and pro-IL-1␤ induction (Fig.  6D) in HIV-R3A-infected THP-1 cells. We also assessed caspase-1 activation by FLICA staining in the presence of HIV-1 inhibitors. Although T20, NVP, AZT, and raltegravir reduced the activity of caspase-1 to the level of mock infection, amprenavir only slightly reduced caspase-1 activation (Fig. 6E) . Consistently, T20, NVP, AZT, and raltegravir, but not amprenavir, significantly attenuated HIV-R3A induced IL-1␤ production in primary monocytes (Fig.  6F) . These data indicate that post-integration products, including HIV-1 RNA or proteins, are required for pro-IL-1␤ expression and NLRP3 inflammasome activation.
HIV-1 RNA Is Sufficient to Induce Pro-IL-1␤ Expression and NLRP3 Inflammasome Activation-TLR8, a sensor of singlestranded RNA, is critical for HIV-1 induced pro-IL-1␤ expression ( Fig. 3) . ssRNA40 is a 20-mer, U-rich, single-stranded RNA derived from the HIV-1 long terminal repeat U5 region, which has been reported to be a TLR8 agonist. ssRNA41 is derived from ssRNA40 by replacement of all U nucleotides with adenosines and is used as a negative control for ssRNA40 (46) . We transfected the HIV-1-derived single-stranded RNA, ssRNA40, or the control ssRNA41 RNA into THP-1 cells. Compared with the control, ssRNA40 induced dramatic production of pro-IL-1␤, active caspase-1 p10, and cleaved IL-1␤ p17 (Fig.  7A) , indicating that HIV-1-derived RNA is sufficient for both pro-IL-1␤ expression and caspase-1 activation. Furthermore, ssRNA40-induced caspase-1 activation and IL-1␤ release were abolished in NLRP3 and ASC knockdown THP-1 cells (Fig. 7, B and C). However, ssRNA40-induced pro-IL-1␤ expression was not affected in THP-1 cells with attenuated NLRP3 and ASC expression ( Fig. 7D) . Even though the ssRNA40 RNA was transfected into the cytosol, its induction of pro-IL-1␤ was still dependent on TLR8 (Fig. 7E) , which is consistent with the data in Fig. 3 . Our data suggest that HIV-1 RNAs produced after the integration of the HIV-1 proviral genome can induce pro-IL-1␤ expression and activate the NLRP3 inflammasome.
DISCUSSION
HIV-1 disease progression is associated with elevated levels of inflammatory cytokines such as IL-1␤. However, the mech- anism by which HIV-1 infection leads to IL-1␤ production is not clear. IL-1␤ production requires both the induction of pro-IL-1␤ gene expression and activation of the inflammasome complex (13) . We report here that HIV-1 infection induced expression of pro-IL-1␤ through TLR8-dependent mechanisms and IL-1␤ maturation via NLRP3 inflammasome-dependent mechanisms in human monocytic cells. Interestingly, HIV-1 replication steps, including entry, reverse transcription, and integration, but not virion maturation, were all required. We report that HIV-1-induced ROS and cathepsin B were required for the activation of the NLRP3 inflammasome. It has been reported previously that there are no differences in the IL-1␤ pattern in HIV-1-infected versus non-infected monocytes (47) (48) (49) . The discrepancy is probably due to the different HIV-1 strains or the lower multiplicity of infection used in previous experiments.
During influenza virus infection, viral genomic RNA is endocytosed to activate TLR7 in the endosome of monocytes, which induces pro-IL-1␤ gene expression (25) . In this study, soluble CD4 completely abrogated both the induction of pro-IL-1␤ expression and caspase-1 activation by HIV-1. We discovered that HIV-1 infection induced pro-IL-1␤ expression via TLR8, but not TLR7, in monocytes, although both TLR7 and TLR8 can be activated by HIV-1 infection (8 -12) . As expected, inhibitors of endosome acidification, which can disrupt endosomal TLR function, also blocked HIV-induced pro-IL-1␤ expression.
The NLRP3 inflammasome is activated by a number of different stimuli, but the molecular mechanisms are undefined (15) . It is not clear how HIV-1 infection activates the NLRP3 inflammasome, although cathepsin B activity and induction of ROS were required. We show that HIV-1-productive infection was required for both pro-IL-1␤ expression and inflammasome activation, suggesting a novel mechanism for inflammasome activation and IL-1␤ production. We quantified the total HIV-1 RNA in the cell and found that the cathepsin B inhibitor CA-074 Me did not affect HIV-1 RNA accumulation, whereas chloroquine and the ROS inhibitor APDC only slightly reduced HIV-1 RNA expression, thus excluding the possibility that the inhibition of pro-IL-1␤ by chloroquine and inhibition of NLRP3 inflammasome activation and IL-1␤ production by APDC or CA-074 Me is due to the inhibition of HIV-1 replication. Specific HIV-1-derived RNAs and/or HIV-1-encoded proteins may contribute to inflammasome activation. For the influenza virus, activation of the NLRP3 inflammasome requires the virus-encoded M2 protein, a proton-selective ion channel protein (25) . Of interest is the HIV-1 accessory protein Vpu, whose transmembrane domain also acts as an ion channel (50) . Expression of each HIV-1 encoded ORF alone in THP1 cells and primary macrophages showed no significant effect on inflammasome activation. 3 However, transfection of HIV-1derived single-stranded RNA into THP-1 cells induced significant caspase-1 activation and IL-1␤ production. It seems that HIV-1 activates NLRP3 through its RNA but not the ion channel protein Vpu. It is possible that HIV-1 RNA accumulation triggered ROS production and cathepsin B release from the lysosome, which contribute to NLRP3 inflammasome activation. It will be interesting to define the specific HIV-1 RNA 3 Guo, H., and Su, L., unpublished data. sequences and the receptors required for HIV-1-induced NLRP3 inflammasome activation in future experiments.
Consistent with our findings, HIV-1 disease progression is associated with activated macrophages and increased levels of IL-1␤ (51) , which likely lead to immune dysregulation and CD4 T cell depletion. Therefore, reducing the IL-1␤ level or activity in vivo is likely beneficial to HIV-1 patients. This hypothesis will be tested in the humanized mouse models of HIV pathogenesis (52) (53) (54) or in the simian immunodeficiency virus-infected rhesus monkey models (55-58) using IL-1␤neutralizing antibodies.
